NEWS & EVENTS

Latest news and upcoming events

Memo Therapeutics increases Series C financing to CHF 45 million
07 May 2024

Memo Therapeutics increases Series C financing to CHF 45 million

Upcoming events

  • Bio€quity Europe
    14 - 16 May 2024,
    San Sebastián

    download

  • AseBio Investor Day 2024
    15 May 2024,
    San Sebastián

    download

  • ESMO Congress 2024
    13 - 19 September 2024,
    Barcelona

    download
SpliceBio Appoints Leading Ophthalmology Expert Aniz Girach as Chief Medical Officer Retinal Disease<
03 Jan 2024

SpliceBio Appoints Leading Ophthalmology Expert Aniz Girach as Chief Medical Officer Retinal Disease

Appointment further strengthens SpliceBio’s leadership team as it accelerates lead program targeting Stargardt disease towards clinical development
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension<
21 Dec 2023

Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension

Topline data from ongoing Advance-HTN pivotal trial expected in 2H 2024
Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors<
18 Dec 2023

Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors

Under the terms of the agreement, Biocytogen will grant Ona access to evaluate Biocytogen’s proprietary RenMice®-derived fully human antibodies against a specific tumor target.
Inbiomotion and The Scientific Group sign an exclusive distribution agreement of MAF Test® for the Sub-Saharan Africa<
13 Dec 2023

Inbiomotion and The Scientific Group sign an exclusive distribution agreement of MAF Test® for the Sub-Saharan Africa

MAF Test® will benefit an estimated 10,200 new patients each year just in South Africa
CorWave announces the appointment of Fairuz Hasni as Vice President Human Resources<
05 Dec 2023

CorWave announces the appointment of Fairuz Hasni as Vice President Human Resources

Fairuz Hasni has over twenty years of experience in industrial companies.
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023<
17 Nov 2023

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023

aXess demonstrated exceptional patency rates and no infections to date
Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX<
16 Nov 2023

Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX

CALYX has been designed as a Phase 3 trial to confirm the disease modifying potential of leriglitazone

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update<
13 Nov 2023

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Enrollment ongoing in CHASE Phase 2b clinical trial of KPI-012 for PCED
Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023<
11 Nov 2023

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023

New analysis on serum leptin levels among patients in the Target-HTN Phase 2 trial adds to emerging evidence of positive feedback loop linking obesity, leptin and aldosterone.
Publication in Nature Cell Biology deciphers the mechanism by which the MAF protein promotes breast cancer metastasis<
10 Nov 2023

Publication in Nature Cell Biology deciphers the mechanism by which the MAF protein promotes breast cancer metastasis

Results opens the possibility of an additional clinical utility of MAF Test®.

Newsletter

subscribe

Subscribe to our weekly newsletter for the latest
updates on life sciences investments.

Bitplex 360 Кракен даркнет кракен даркнет Blacksprut Blacksprut Кракен ссылка кракен ссылка